Answer
Among 1,722 adults with ALK-positive or ROS1-positive NSCLC in clinical studies, the most frequent adverse reactions associated with crizotinib dosing interruptions (≥3%) were neutropenia, elevated transaminases, vomiting and nausea.
Sources for this answer
- Xalkori 200mg hard capsulePfizer Limited · emc · SmPC §4.2 Posology and method of administration · Version 37Document updated
Sources checked